Establishment Labs Holdings Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
1,004
- Stock Symbol
-
ESTA
- Investments
-
3
- Share Price
-
$69.21
- (As of Friday Closing)
Establishment Labs Holdings General Information
Description
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
Contact Information
Website
www.establishmentlabs.comCorporate Office
- Coyol Free Zone, B15
- Alajuela
- Costa Rica
Corporate Office
- Coyol Free Zone, B15
- Alajuela
- Costa Rica
Establishment Labs Holdings Timeline
Establishment Labs Holdings Stock Performance
As of 20-Nov-2026, Establishment Labs Holdings’s stock price is $69.21. Its current market cap is $2.06B with 29.8M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $69.21 | $69.61 | $53.16 - $97.59 | $2.06B | 29.8M | 414K | -$1.28 |
Establishment Labs Holdings Financials Summary
As of 30-Sep-2026, Establishment Labs Holdings has a trailing 12-month revenue of $264M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 2,104,904 | 2,308,274 | 1,484,774 | 804,976 |
| Revenue | 264,029 | 211,076 | 166,025 | 165,151 |
| EBITDA | (8,013) | (22,715) | (57,699) | (59,327) |
| Net Income | (38,454) | (51,064) | (84,596) | (78,502) |
| Total Assets | 358,876 | 357,167 | 346,831 | 268,641 |
| Total Debt | 269,529 | 264,467 | 225,294 | 192,224 |
Establishment Labs Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Establishment Labs Holdings Comparisons
Industry
Financing
Details
Establishment Labs Holdings Competitors (7)
One of Establishment Labs Holdings’s 7 competitors is Integra LifeSciences Holdings, a Corporation company based in Princeton, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Integra LifeSciences Holdings | Corporation | Princeton, NJ | ||||
| Medtronic | Corporation | Minneapolis, MN | ||||
| Novo Nordisk | Corporation | Bagsvaerd, Denmark | ||||
| Cutera | Formerly VC-backed | Brisbane, CA | ||||
| Lumenis | Private Equity-Backed | Yokneam, Israel |
Establishment Labs Holdings Patents
Establishment Labs Holdings Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026093796-A1 | Scaffold sheet for promoting tissue formation | Pending | 30-Oct-2024 | ||
| EP-4642385-A2 | Minimally invasive implant procedure and system | Pending | 29-Dec-2022 | ||
| US-20260026927-A1 | Minimally invasive implant procedure and system | Pending | 29-Dec-2022 | ||
| WO-2024141785-A2 | Minimally invasive implant procedure and system | Inactive | 29-Dec-2022 | ||
| WO-2024141785-A3 | Minimally invasive implant procedure and system | Inactive | 29-Dec-2022 | A61F2/12 |
Establishment Labs Holdings Signals
Establishment Labs Holdings Investments & Acquisitions (3)
Establishment Labs Holdings’s most recent deal was a Corporate Asset Purchase with AFS Medical (Inventory, Customer Relationships And Contracts) for . The deal was made on 31-Jan-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| AFS Medical (Inventory, Customer Relationships And Contracts) | 31-Jan-2019 | Corporate Asset Purchase | Buildings and Property | ||
| Femiline (certain assets) | 17-Nov-2017 | Merger/Acquisition | Distributors (Healthcare) | ||
| Magna Equities I (Certain Assets) | 01-Nov-2015 | Corporate Asset Purchase | Buildings and Property |
Establishment Labs Holdings ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
36.53 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Establishment Labs Holdings FAQs
-
When was Establishment Labs Holdings founded?
Establishment Labs Holdings was founded in 2004.
-
Where is Establishment Labs Holdings headquartered?
Establishment Labs Holdings is headquartered in Alajuela, Costa Rica.
-
What is the size of Establishment Labs Holdings?
Establishment Labs Holdings has 1,004 total employees.
-
What industry is Establishment Labs Holdings in?
Establishment Labs Holdings’s primary industry is Therapeutic Devices.
-
Is Establishment Labs Holdings a private or public company?
Establishment Labs Holdings is a Public company.
-
What is Establishment Labs Holdings’s stock symbol?
The ticker symbol for Establishment Labs Holdings is ESTA.
-
What is the current stock price of Establishment Labs Holdings?
As of 20-Nov-2026 the stock price of Establishment Labs Holdings is $69.21.
-
What is the current market cap of Establishment Labs Holdings?
The current market capitalization of Establishment Labs Holdings is $2.06B.
-
What is Establishment Labs Holdings’s current revenue?
The trailing twelve month revenue for Establishment Labs Holdings is $264M.
-
Who are Establishment Labs Holdings’s competitors?
Integra LifeSciences Holdings, Medtronic, Novo Nordisk, Cutera, and Lumenis are some of the 7 competitors of Establishment Labs Holdings.
-
What is Establishment Labs Holdings’s annual earnings per share (EPS)?
Establishment Labs Holdings’s EPS for 12 months was -$1.28.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process